
Temperature excursions cost pharma an estimated $35 billion a year as biologics, GLP-1s and cell and gene therapies raise cold chain stakes.
Cold Chain Technologies looks into shipping practices
The survey is quick and straightforward, with questions on practices involving performance qualification (PQ), temperature monitoring, spending and staffing for tertiary packaging, and sustainability initiatives, all of these are very much in motion as the indsutry adapts to global distribution practices (GDPs) mandated in various parts of the world.
go to the survey






